Summit Trail Advisors’s Nu Skin NUS Stock Holding History

Summit Trail Advisors’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-57	Closed	-$4K	–	1258
2017 Q4	$4K	Buy	+57	New	+$3.69K	﹤0.01%	1477

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Summit Trail Advisors's NUS Position: Q1 2018 in Review

Summit Trail Advisors sold out of Nu Skin (NUS) in Q1 2018, closing a stake of 57 shares — an estimated $4K sold.

Summit Trail Advisors first reported a position in NUS in Q4 2017 and held it in 1 quarter. The position peaked at $4K in Q4 2017. 295 funds tracked by Wall St. Rank hold NUS as of Q1 2018.

Summit Trail Advisors reported no remaining Nu Skin position as of Q1 2018 after selling out during the quarter.
Summit Trail Advisors sold 57 Nu Skin shares in Q1 2018, an estimated $4K.
Summit Trail Advisors first reported a position in Nu Skin in Q4 2017 and held it in 1 quarter.
Summit Trail Advisors's Nu Skin position peaked at $4K in Q4 2017.
295 funds tracked by Wall St. Rank held Nu Skin as of Q1 2018.

Based on Summit Trail Advisors's 13F filing for Q1 2018, filed 21 May 2018.